indacrinone has been researched along with Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhushan, S; Chanda, D; Guru, SK; Luqman, S; Mondhe, DM; Negi, AS; Pal, A; Rah, BA; Shanker, K; Wani, ZA | 1 |
1 other study(ies) available for indacrinone and Breast Neoplasms
Article | Year |
---|---|
Anticancer activity, toxicity and pharmacokinetic profile of an indanone derivative.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Female; Humans; Indans; Leukocytes; Male; Mice; NF-kappa B; Rabbits; Tubulin Modulators | 2012 |